drugset / Trial / NCT04932252
A Study of A4368 in Healthy Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A4368 is the autophagy activator that is being developed for the treatment of nonalcoholic steatohepatitis. The goal of the study is to assess the safety, tolerability, and pharmacokinetics in healthy subjects.
Timeline
- Start
- 2021-09-07
- Primary completion
- 2022-07-25
- Completion
- 2022-07-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | A4368 | Unknown | — | Oral |
Indications
No indication recorded.